A world‑first targeted screening program using accredited polygenic risk score (PRS) testing to pinpoint which relatives of glaucoma patients face the greatest genetic risk
De Rigo has announced significant changes to its team with the departure of Chris Hanley, National Sales Manager, who has been with the business
Bausch and Lomb has launched PreserVision AREDS3 eye vitamins in the United States.
Applications are invited for Optometry Australia’s July 2026 Advanced Practice Recognition (APR) program, which focuses on glaucoma care.
DISCLAIMER : THIS WEBSITE IS INTENDED FOR USE BY HEALTHCARE PROFESSIONALS ONLY.
By agreeing & continuing, you are declaring that you are a registered Healthcare professional with an appropriate registration. In order to view some areas of this website you will need to register and login.
If you are not a Healthcare professional do not continue.
